Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs.

Biotechnology

Icosavax

Icosavax's headquarters in Seattle, WA, United States

Thalia Nguyen

Ami Shah Brown

Brendan Mullin

Geremy Knapp

M. Amin Khan

Amin Khan

Lori Stewart

Raymund Legaspi

Adrian DuPre

Margaret MacDonald

Kevin DeGiusti

Peter de Vries

W. Jacob Ezzell

Sonja Baron

James Wassil

Neil King

Ann Veneman

Heidi Kunz

Christian Mandl

Mark McDade

David Baker

Jean-Paul Prieels

Peter Kolchinsky

Robin Robinson

Ralf Clemens

The Research and Scientist Team at Icosavax is dedicated to the discovery and development of innovative vaccine candidates. They conduct cutting-edge research, perform in-depth immunological studies, and collaborate on preclinical and clinical trials to address unmet medical needs in infectious diseases, ultimately contributing to safer and more cost-effective healthcare solutions.

Research and Scientist Team

The Operations Team at Icosavax ensures the seamless execution of business processes, project management, clinical operations, quality assurance, and drug substance and product operations to support the development of vaccines. This team orchestrates cross-functional efforts to maintain high standards and efficiency in advancing clinical and preclinical programs, ensuring regulatory compliance and operational excellence.

Operations Team

The Leadership Team at Icosavax comprises top executives responsible for driving the company's strategic vision and operational execution. They collaborate to advance the development of innovative vaccines, ensure regulatory compliance, and manage partnerships, ultimately aiming to meet unmet medical needs and enhance public health while optimizing healthcare costs.

Leadership Team

The Scientific Advisory Board at Icosavax provides expert guidance and strategic direction for the company's vaccine development efforts. Comprising leading scientists and researchers, the board evaluates research progress, advises on scientific methodologies, and ensures the alignment of R&D initiatives with the latest advancements in infectious disease prevention.

Scientific Advisory Board

The Regulatory and Medical Affairs team at Icosavax ensures that vaccine development complies with global regulatory standards and effectively navigates approval processes. They are responsible for clinical trial oversight, regulatory submissions, medical policy development, and maintaining high standards of safety and efficacy throughout the product lifecycle.

Regulatory and Medical Affairs

The Finance and Accounting Team at Icosavax oversees financial planning, budgeting, and reporting to ensure resource allocation aligns with the company's mission to develop critical vaccines. They manage accounting operations, ensure compliance with financial regulations, and provide strategic financial insights to support business growth and reduce healthcare costs.

Finance and Accounting Team

Icosavax

Org chart

Board & advisors

Teams

Research and Scientist Team

Operations Team

Leadership Team

Scientific Advisory Board

Regulatory and Medical Affairs

Finance and Accounting Team

Offices

Icosavax

Org chart

Board & advisors

Teams

Research and Scientist Team

Operations Team

Leadership Team

Scientific Advisory Board

Regulatory and Medical Affairs

Finance and Accounting Team

Offices

Related companies